Robert A. Carr
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Receptor Mechanisms and Signaling 5
- Oncology 9
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Jonathan M. Miller (3 shared papers)Arik Dahan (2 shared papers)Avital Beig (2 shared papers)Julie K. Spence (2 shared papers)Hugo Geerts (9 shared papers)Äthan Spiros (9 shared papers)Patrick J. Roberts (7 shared papers)Robert T. Foster (5 shared papers)
- Journals
- Biopharmaceutics & Drug Disposition (3 papers)Journal of Pharmaceutical Sciences (3 papers)Blood (2 papers)Journal of Clinical Oncology (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Robert A. Carr
40 papers receiving 982 citations
Peers
Comparison fields: 5 of 105
- Pharmaceutical Science 351
- Pharmacology 97
- Analytical Chemistry 82
- Spectroscopy 132
- Oncology 178
Countries citing papers authored by Robert A. Carr
This map shows the geographic impact of Robert A. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Carr more than expected).
Fields of papers citing papers by Robert A. Carr
This network shows the impact of papers produced by Robert A. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Carr. The network helps show where Robert A. Carr may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Carr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 230 | |
| 2 | 2015 | 72 | |
| 3 | 2010 | 67 | |
| 4 | 2017 | 61 | |
| 5 | 2021 | 51 | |
| 6 | 2013 | 51 | |
| 7 | 1992 | 51 | |
| 8 | 2013 | 38 | |
| 9 | 2002 | 34 | |
| 10 | 1991 | 34 | |
| 11 | 1997 | 30 | |
| 12 | 2013 | 29 | |
| 13 | 2007 | 27 | |
| 14 | 1990 | 26 | |
| 15 | 1995 | 23 | |
| 16 | 2008 | 23 | |
| 17 | 2013 | 21 | |
| 18 | 2012 | 19 | |
| 19 | 1997 | 18 | |
| 20 | 2009 | 17 |
About Robert A. Carr
Robert A. Carr is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Genetics, having authored 43 papers that have together received 1.0k indexed citations. Recurring topics across this work include Blood disorders and treatments (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Receptor Mechanisms and Signaling (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Computational Drug Discovery Methods (5 papers), Neonatal and Maternal Infections (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Drug Solubulity and Delivery Systems (3 papers). The work is most often cited by research in Pharmaceutical Science (351 citations), Pharmacology (97 citations), Analytical Chemistry (82 citations), Spectroscopy (132 citations) and Oncology (178 citations). Robert A. Carr has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jonathan M. Miller, Arik Dahan, Avital Beig, Julie K. Spence, Hugo Geerts, Äthan Spiros, Patrick J. Roberts, Robert T. Foster, Neena Modi and J. M. Davies. Their work appears in journals such as Biopharmaceutics & Drug Disposition, Journal of Pharmaceutical Sciences, Blood, Journal of Clinical Oncology and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.